Dr. Nicholas Zorko is a physician-scientist at the University of Minnesota Masonic Cancer Center.  He completed his MD/PhD training at the Ohio State University and continued his residency and fellowship training in hematology/oncology at the University of Minnesota.  His clinical practice focuses on genitourinary malignancies and cellular therapies to treat solid tumors.  His translational lab seeks to develop novel natural killer cell immune engagers and engineered effector cells to treat genitourinary malignancies.  He is a Prostate Cancer Foundation Young Investigator and is also funded by the Department of Defense to develop novel natural killer cell therapies.  He is currently the site principal investigator for industry-sponsored immune engager studies targeting PSMA and B7-H3 offered at the University of Minnesota's Masonic Cancer Center.